Skip to content
Screener

Arbutus Biopharma Corporation ABUS Q1 2025 earnings

Reported May 14, 2025 · Before market open

Revenue$1.8MMiss by $477.9K
EPS-$0.13Miss by $0.04
Revenue estimate$2.2M
EPS estimate-$0.09

Next report

Nov 16, 2026 (in a month)
Revenue estimate$1.0M
EPS estimate-$0.02

Financials

Q1 2025

Income statement

See full
Revenue$1.8M+15.1%
Operating income-$25.7M-32.7%
Net income-$24.5M-37.2%
EPS (diluted)-$0.13-30.0%

Balance sheet

See full
Cash & equivalents$37.1M-14.0%
Total debt$1.2M-29.4%
Total equity$79.2M-30.9%
Total assets$117.0M-22.1%

Cash flow

See full
Operating cash flow-$13.4M+30.6%
CapEx--100%
Free cash flow-$13.4M+30.9%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$668.27M+44.3%
Enterprise value$632.38M+50.0%
P/S104.4×+68.7×

Profitability

See full
Operating margin-1,290.9%-15,019pp
Net margin-1,195.9%-14,830pp
FCF margin-922%+987pp

Returns & leverage

See full
Return on equity-79%+47.1pp
Debt / equity0×0.0×
Current ratio6×-0.7×

Segments

By product

See full
Collaborations and licenses$1.3M—
Revenue from collaborations and licenses$812.0K+16.8%
Non-cash royalty revenue$448.0K-24.5%

By segment

See full
Reportable Segment$1.8M+15.1%

FAQ

When did Arbutus Biopharma Corporation report Q1 2025 earnings?
Arbutus Biopharma Corporation (ABUS) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Arbutus Biopharma Corporation's Q1 2025 revenue and EPS?
Arbutus Biopharma Corporation reported revenue of $1.8M and eps of $-0.13 for Q1 2025.
Did Arbutus Biopharma Corporation beat estimates in Q1 2025?
Revenue missed the consensus estimate of $2.2M by $477.9K. EPS missed the consensus estimate of $-0.09 by $0.04.
How did Arbutus Biopharma Corporation's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 15.1% from $1.5M a year earlier and eps declined 30.0% from $-0.10.
Where can I find Arbutus Biopharma Corporation's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-003153) and the 10-Q periodic report (0001447028-25-000099) directly on SEC EDGAR. The filing index links above go to sec.gov.